Find Events
or
Building a CMC Scorecard for Drug Development Risk Assessment
Registration
Webinar PLUS Audio CD/Transcript - July 23, 2013 <p>
<b><i><span style="color: #ff0000">Best Value! Save $147!</span></i></b><br />
You’ll have access to one log-in and dial-in for the live 90-minute webinar for unlimited participants. You also receive all presentation materials and the opportunity to ask question by phone and email, <i>plus</i> an audio CD and transcript for the entire session.
</p>
$547.00
Webinar Only - July 23, 2013 <p>
You get one log-in and dial-in for the live 90-minute webinar for unlimited participants, presentation materials and the opportunity to ask question by phone and email.
</p>
$347.00
24/7 ENCORE Audio Presentation PLUS Audio CD/Transcript - July 23, 2013 <p>
You'll have access to one dial-in for an archived recording of the entire 90-minute webinar, including the Q&A period, <i>for unlimited participants</i>.
You can dial in any time of day or night for three weeks, from July 29 – Aug. 16, 2013. You'll also receive all presentation materials, <i>plus</i> an audio CD and transcript for the entire session.
</p>
$547.00
24/7 ENCORE Audio Presentation - July 23, 2013 <p>
You'll have access to one dial-in for an archived recording of the entire 90-minute webinar, including the Q&A period, <i>for unlimited participants</i>.
You can dial in any time of day or night for three weeks, from July 29 – Aug. 16, 2013. You'll also receive all presentation materials.
</p>
$347.00
24/7 ENCORE Audio Presentation PLUS Audio CD/Transcript - July 23, 2013
$547.00
24/7 ENCORE Audio Presentation - July 23, 2013
$347.00
Building a CMC Scorecard for Drug Development Risk Assessment - Webinar CD/Transcript
List Price
Our Price
Quantity
Audio CD/Transcript - July 23, 2013
$347.00
Audio CD/Transcript - July 23, 2013
$313.00
Audio CD/Transcript - July 23, 2013
$295.00
Audio CD/Transcript - July 23, 2013
$277.00
Audio CD/Transcript - July 23, 2013
$261.00
Webinar PLUS Audio CD/Transcript - July 23, 2013 <p>
<b><i><span style="color: #ff0000">Best Value! Save $147!</span></i></b><br />
You’ll have access to one log-in and dial-in for the live 90-minute webinar for unlimited participants. You also receive all presentation materials and the opportunity to ask question by phone and email, <i>plus</i> an audio CD and transcript for the entire session.
</p>
$547.00
Webinar Only - July 23, 2013 <p>
You get one log-in and dial-in for the live 90-minute webinar for unlimited participants, presentation materials and the opportunity to ask question by phone and email.
</p>
$347.00
24/7 ENCORE Audio Presentation PLUS Audio CD/Transcript - July 23, 2013 <p>
You'll have access to one dial-in for an archived recording of the entire 90-minute webinar, including the Q&A period, <i>for unlimited participants</i>.
You can dial in any time of day or night for three weeks, from July 29 – Aug. 16, 2013. You'll also receive all presentation materials, <i>plus</i> an audio CD and transcript for the entire session.
</p>
$547.00
24/7 ENCORE Audio Presentation - July 23, 2013 <p>
You'll have access to one dial-in for an archived recording of the entire 90-minute webinar, including the Q&A period, <i>for unlimited participants</i>.
You can dial in any time of day or night for three weeks, from July 29 – Aug. 16, 2013. You'll also receive all presentation materials.
</p>
$347.00
24/7 ENCORE Audio Presentation PLUS Audio CD/Transcript - July 23, 2013
$547.00
24/7 ENCORE Audio Presentation - July 23, 2013
$347.00
Building a CMC Scorecard for Drug Development Risk Assessment - Webinar CD/Transcript
List Price
Our Price
Quantity
Audio CD/Transcript - July 23, 2013
$347.00
Audio CD/Transcript - July 23, 2013
$313.00
Audio CD/Transcript - July 23, 2013
$295.00
Audio CD/Transcript - July 23, 2013
$277.00
Audio CD/Transcript - July 23, 2013
$261.00
When
Event Description
Join presenter Bryan Knox as he teaches you how to use a quantitative-based scoreboard approach that will enable you to identify drug program risks and provide you with a method to evaluate critical areas in the drug development process. This approach, which has been validated by 12 years of evaluations involving hundreds of different drug candidates, will enable you to determine if your product is ready for market or if you have to go back to the drawing board.